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Abstract
Background: Recent evidence suggests that epithelial cancers, including colorectal cancer are driven by a small
sub-population of self-renewing, multi-potent cells termed cancer stem cells (CSCs) which are thought to be
responsible for recurrence of cancer. One of the characteristics of CSCs is their ability to form floating spheroids
under anchorage-independent conditions in a serum-free defined media. The current investigation was undertaken
to examine the role of Wnt/b-catenin pathway in regulating the growth and maintenance of colonospheres.
Human colon cancer cells HCT-116 (p53 wild type; K-ras mutant), HCT-116 (p53 null; K-ras mutant) and HT-29 (p53
mutant) were used.
Results: Colonospheres formed in vitro exhibited higher expression of colon CSCs markers LGR5, CD44, CD166 and
Musashi-1 along with putative CSC marker EpCAM, compared to the corresponding parental cancer cells and also
exhibit the ability to form spheroids under extreme limiting dilution, indicating the predominance of CSCs in
colonospheres. Colonospheres formed by HCT-116 cells show over 80% of the cells to be CD44 positive, compared
to ≤ 1% in the corresponding parental cells. Additionally, colonospheres showed reduced membrane bound
b-catenin but had increased levels of total b-catenin, cyclin-D1 and c-myc and down regulation of axin-1 and
phosphorylated b-catenin. Increased expression of b-catenin was associated with a marked transcriptional
activation of TCF/LEF. The latter was greatly decreased following down regulation of b-catenin by the
corresponding siRNA, leading to a marked reduction in CD44 positive cells as well as colonospheres formation. In
contrast, upregulation of c-myc, a down-stream effector of TCF/LEF greatly augmented the formation of
colonospheres.
Conclusion: Our data suggest that colonospheres formed by colon cancer cell lines are highly enriched in CSCs
and that Wnt/b-catenin pathway plays a critical role in growth and maintenance of colonospheres.
Background
A growing body of evidence supports the contention
that epithelial cancers including the colorectal cancer
are diseases driven by a small set of self renewing cells,
termed cancer stem cells (CSC) or cancer-initiating
cells, that are distinct from the bulk of the cells in the
tumor [1]. Initially identified in hematopoietic tumors,
CSCs have now been identified and isolated in a variety
of solid tumors that include breast, central nervous sys-
tem, pancreas, skin, head and neck, colon and prostate
[2-7]. CSCs share all the fundamental traits of stem
cells-self renewal by asymmetric division, reduced
proliferation and differentiation and resistance to apop-
tosis [8]. CSCs are identified by specific surface epitopes,
which in the colon include CD44, CD133 and CD166
[9,10]. To select putative colorectal CSCs, a promising
combination of three markers- EpCAM, CD44 and
CD166 was described by Dalerba et al. [11]. Although
EpCAM previously being considered as pan-epithelial
marker in the normal human colon, its frequent expres-
sion in CSCs in breast, colon, pancreas and prostate
tumors suggests that this surface epitope could be a
putative marker for CSCs, particularly in human colon
cancer-derived cell lines [12]. More recently Lgr5,
Musashi-1 and aldehyde-dehydrogenase 1 (ALDH-1)
have been added to the list of stem cell markers for
colon cancer [13-15].
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derived CSCs is that they can be grown to form spheri-
cal colonies in vitro, when plated in limited numbers
under anchorage-independent conditions in a serum-
free defined media supplemented with growth factors
[9]. With the objectives to promoting in vitro expan-
sions of CSCs, methods have been developed to grow
and study them in sphere-forming assays as reported for
neurospheres [16,17], mammospheres [18,19] and colo-
nospheres [13,20]. Using this approach, we and others
have identified and/expanded colon CSCs by generating
colonospheres from colon cancer cell lines [10,21-24].
However, little is known about the signaling events that
regulate the growth and maintenance of colonospheres.
Different signaling pathways such as Wnt, Hedgehog,
Notch and Bmi have been implicated in various cellular
processes during development that include differentia-
tion, migration and proliferation [25-27]. Recent studies
have reported the pivotal role of Wnt/b-catenin signal-
ing pathway in the regulation of epithelial stem cell self
renewal [28,29]. In contrast, dysregulation of Wnt/b-
catenin signaling has been implicated in colon carcino-
genesis [30,31]. However, the regulatory role of Wnt/
b-catenin signaling in the maintenance and growth of
colonospheres still remains elusive. The current investi-
gation was, therefore, undertaken to study the in vitro
expansion of colonospheres that display the characteris-
tics of CSCs and to delineate the role of Wnt/b-catenin
pathway in regulating the growth and maintenance of
colonospheres using three different human colon cancer
cells: HCT-116 (p53 wild-type; K-ras mutant), HCT-116
(p53 null; K-ras mutant) and HT-29 (p53 mutant, K-ras
wild-type).
Results
Generation and characterization of colonospheres
Recently, we reported that FOLFOX-surviving colon
cancer cells that are enriched in CSCs grow in large
round, unattached floating spheroid colonies (termed
colonospheres) when cultured in chemically defined
serum-free medium at a relatively low density [22]. In
agreement with our previous observation, our current
results also show that colon cancer cells, whether they
are p53-positive (HCT-116 wt) or p53-negative (HCT-
116p53
-/- and HT-29) form spheroid colonies in a che-
mically defined media (Figure 1A). The spheroids
formed by these cells showed higher levels of EpCAM
(also known as epithelial specific antigen or ESA) along
with colon CSC markers-CD44, Musashi-1 and LGR-5
than the corresponding parental cells (Figure 1B). When
the proportion of the CD44 positive cells was deter-
mined by flow cytometry in parental cells and colono-
spheres, they were found to be ≤ 1% in parental cell
lines (Figure 2A), as opposed to more than 80%
observed in colonospheres (Figure 2B). The results sug-
gest that colonospheres formed by the colon cancer
cells are enriched in CSCs. Indeed, when the colono-
spheres formed by HCT-116 cells were subjected to
immunofluorescence staining for EpCAM, we observed
bright EpCAM staining on the cell surface of each cell
Figure 1 CSC markers in colon cancer cells and spheroids/colonospheres. A. Representative photographs showing different colon cancer
cells (HT-29, HCT-116 wt & p53-null) in adherent condition and colonospheres formed by the respective cell lines. B. The comparative expression
of different CSC markers in parental colon cancer cells (referred to as ‘P’) and the cells from corresponding spheroids (referred to as ‘S’). The
numbers represent percent of corresponding control normalized to b-actin.
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colonosphere (Figure 2B).H o w e v e r ,s i n c eE p C A Mi s
also expressed in normal human epithelial cells as well
as in gastrointestinal carcinomas, we carried out the
next set of experiments to validate and quantitate the
presence of functional CSCs in colonospheres (within
the confines of an in vitro system). We determined the
frequency of sphere-forming cells by performing an
extreme limiting dilution analysis (ELDA) for parental
and colonospheres-derived HCT-116 cells. The fre-
quency to form spheroids was found to be 5.5 fold
higher for cells derived from colonospheres than those
from the parent cell line (Table 1).
Like normal stem cells, CSCs are also poorly differen-
tiated and proliferate slowly [32]. To determine the
extent of differentiation of colon CSC, colonospheres
formed by HCT-116wt, HCT-116p53-null and HT-29
cells and the corresponding parental cells were assayed
for alkaline phosphatase activity. The results revealed a
50-55% reduction in alkaline phosphatase activity in
colonospheres when compared with their corresponding
parental cells (Figure 3A). Further, to determine whether
cells in colonospheres can be induced to differentiate,
they were incubated for 24 h with 1 mM sodium buty-
rate, a known differentiation inducing agent [33].
Sodium butyrate caused a 2-fold increase in alkaline
phosphatase activity in colonospheres, compared to the
controls (Figure 3B). Since colonospheres are composed
of cells that display the characteristics of CSCs, we
examined their proliferative potential. When cells from
Figure 2 Spheroids/colonospheres display increased levels of CSC markers. A. Representative scattered plots of flow cytometry analyses of
CD44 positive cells in different colon cancer cells: Figures in the left panel depict the parental colon cancer cells stained with PerCP-Cy5 mouse
IgG2b (Isotype), whereas those in the right panel, show the cells treated with CD44 conjugated PerCP-Cy5 mouse anti-human antibodies. Values
represent percentage of cells that are positive for CD44-PerCP-Cy5. B. Photomicrographs showing the integrity and viability of colonospheres
(HCT-116) using acridine orange-ethidium bromide (AO-EtBr) staining and immunofluorescence staining depicting the membrane bound
expression of putative CSC marker EpCAM (Upper Panel); and flow cytometric analysis showing the proportion of CD44 positive cells in HCT-116
colonospheres-derived cells. Corresponding isotype for CD44 antibodies is shown (Lower Panel).
Kanwar et al. Molecular Cancer 2010, 9:212
http://www.molecular-cancer.com/content/9/1/212
Page 3 of 13colonospheres formed by HCT-116 (wt and p53-null)
and HT-29 were analyzed for cell growth by MTT assay
over a period of 5 days (120 h), we found the growth to
remain 30-40% lower over the corresponding parental
cell lines (Figure 3C).
CSCs are known to be resistant to chemotherapy
because of increased drug efflux capacity [34]. To deter-
mine whether cells in colonospheres that are enriched
in CSCs would also show increased exclusion of drugs,
the cells from HCT-116 colonospheres were subjected
to fluorescence microscopy and flow cytometry analysis
for Hoechst 33342 dye exclusion [35]. A marked 80%
increase in dye exclusion was observed for cells in colo-
nospheres of HCT-116 cells, compared to the parental
cells (Figure 4A, B). This was associated with increased
expression of ABC transporter protein ABCG2 (Figure
4C), a member of the superfamily of ATP-binding cas-
sette (ABC) transporters whose primary function is to
Table 1 Extreme limiting dilution analysis of colonospheres forming frequency of HCT-116 cells, transfected with non-












1000 24 24 24 24
100 24 24 24 10
10 24 24 14 2
12 4 1 4 4 0
Sphere forming frequency (95% CI) 1/2 (1/3-1/2) 1/11 (1/17-1/7) 1/171 (1/287-1/102)
P value << 0.0001
Data are pooled from three independent experiments for each. CI, confidence interval
Figure 3 Differentiation and proliferation potential of parental colon cancer cells and the corresponding spheroids/colonospheres. A.
Spheroids show decreased alkaline phosphatase activity compared to parental colon cancer cells. B. Induction of alkaline phosphatase activity in
the spheroids in response to Na-butyrate. C. Changes in cellular growth of parental cell lines and colonospheres over the period of 5 days as
determined by MTT assay. Each value represents mean ± SD of six observations. *p < 0.001, compared to the corresponding parental cells or
control.
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cellular membranes [34].
The Wnt/b-catenin pathway is activated in colonospheres
The Wnt/b-catenin signaling pathway is known to be
activated in many malignancies, including colorectal
cancer [36]. This signaling pathway also plays a critical
role in regulating the proliferation of CSCs [37]. To
determine the involvement of Wnt/b-catenin signaling
pathway in maintaining the growth and maintenance of
colonospheres, the next set of experiments were carried
out. The immunofluorescence studies revealed a mark-
edly higher staining of membrane bound b-catenin in
HT-29 parental cells, when compared with cells from
the corresponding colonospheres (Figure 5A). Next, we
compared the expression of several members of Wnt/b-
catenin pathway and its downstream targets in the par-
ental monolayer cultures with those of colonospheres.
Western blot analysis revealed a markedly higher
expression of total b-catenin, phospho-GSK-3b and
their downstream effector c-myc and cyclin-D1 in colo-
nospheres from all three cell lines, compared to the cor-
responding parental cells (Figure 5B). In contrast, the
levels of phospho-b-catenin and axin-1 were found to
be considerably lower in colonospheres compared to the
corresponding parental cells (Figure 5B). Taken
together, the results suggest that Wnt/b-catenin signal-
ing is intricately involved in the growth and mainte-
nance of colonospheres.
b-catenin is important for the generation of
colonospheres
To demonstrate whether b-catenin plays a key role in the
generation of colonospheres, we transfected HCT-116
(wt) cells with b-catenin-siRNA or the corresponding
vector (NT-siRNA) to knock-down b-catenin and deter-
mined their sphere-forming frequency by performing an
ELDA (Extreme Limiting Dilution Analysis). The b-cate-
n i nk n o c k - d o w ni nH C T - 1 1 6c e l l sr e v e a l e da1 5 . 5f o l d
decrease in the number of sphere-forming cells, com-
pared to the parental cells (Table1). Since sphere-forming
cells are highly enriched in CSCs that are thought to be
critically involved in the formation of colonospheres, it is
anticipated that knock-down of b-catenin in colono-
spheres-derived cells would reduce CSCs leading to
reduction in colonosphere formation. Indeed, our flow
cytometric analysis revealed that knock-down of b-cate-
nin in colonosphere-derived HCT-116 cells by the corre-
sponding siRNA lead to approximately 87% reduction in
the proportion of CD44 positive cells, when compared
with the vector-transfected controls (Figure 6A). This
observation was further confirmed by Western-blot ana-
lysis which showed that a 77% downregulation of b-cate-
nin was accompanied by a marked 70% reduction in the
levels of CD44 (Figure 6B). Further, to demonstrate that
b-catenin is required for self-renewal of CSCs in colono-
spheres, regeneration or secondary colonospheres forma-
tion assay was carried out following transfection
with b-catenin-siRNA or the corresponding vector
Figure 4 Spheroids/colonospheres-derived cells show increased dye-efflux. A. Photomicrographs showing exclusion of Hoechst-33342
(H342) by HCT-116 colonospheres-derived cells in the absence or presence of verapamil, an inhibitor of membrane ABCG2 transporter protein
(positive control). Propidium Iodide was used to detect dead cells. B. The quantitaion of flow cytometry analysis of H342 dye exclusion by HCT-
116 parental and colonospheres-derived cells. C. Western blot showing changes in the levels of ABCG-2 in HT-29 and HCT-116 wt parental (P)
and colonospheres-derived cells (S). The numbers represent percent of corresponding control normalized to b-actin. *p < 0.01 compared to the
corresponding parental cells.
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in an 80% reduction in secondary colonospheres forma-
tion (Figure 6C). Downregulation of b-catenin also
resulted in a marked reduction in Wnt/b-catenin signal-
ing, as evidenced by the significant 60% and 75%
decreased transcriptional activity of TCF/LEF in HCT-
116 parental cells and colonospheres, respectively, when
compared with the corresponding controls (Figure 7).
To further determine the regulatory role of Wnt/b-
catenin signaling in colonospheres formation, the next
experiment was carried out to examine whether upregu-
lation of c-myc, a downstream target effector gene of
Wnt/b-catenin pathway, in colon cancer cells would
augment formation of colonospheres. Western-blot ana-
lysis revealed that 3 days following transfection of
cDNA for c-myc to HCT-116 cells caused a 7-8 fold
increase in the levels of c-myc, when compared with
vector-transfected controls (Figure 8A). This was
accompanied by a 2.5-fold increase in colonospheres
formation by HCT-116 cells, when compared with the
vector-transfected controls (Figure 8B).
Discussion
Recent studies have suggested that many epithelial can-
cers, including colon cancer arise from a small sub-
population of CSCs through their oncogenic transforma-
tions [38-40]. There is a strong evidence that colon
cancer-derived cell lines represent the tumors from
which they are originally isolated [41] and can develop
structures similar to those found in the original tissue
[42], suggesting the presence of CSCs in colon cancer-
derived cell lines. Much of the advance on CSCs comes
from the assays that have used FACS technology to iso-
late and enrich for CSCs from primary tumors, and
then testing their propagation in immune-deficient mice
[20,43]. Such assays are cumbersome and expensive, and
do not readily enable either the characterization of
CSCs or their functional properties. However, unlike the
primary tumor, the cell lines represent a valuable
resource that can be used repeatedly over time, and can
be readily characterized by various CSCs assays. There
are clearly many advantages to working with CSCs
derived from cell lines, both for the possible develop-
ment of novel targets for drug development, as well as
for the possible development of relatively high-through-
put drug-response assays for CSCs.
In the present work, using an approach to culture cells
that display markers and characteristics of CSCs, we
show that spheroid cultures (or colonospheres) gener-
ated from a limited number of human colon cancer-
derived cell lines are enriched for cells that express
colonic CSC markers. Widely accepted general charac-
teristics of “stemness” include the expression of putative
stem cell antigens, reduced cell cycle progression, and
Figure 5 Activation of Wnt/b-catenin signaling pathway in spheroids/colonospheres. A. Representative photomicrographs of HT-29
parental and colonospheres-derived cells depicting the membrane localization of b-catenin by immunofluorescence staining. B. The comparative
expression of different members of Wnt/b-catenin signaling pathway in parental cells (referred to as ‘P’) and colonospheres-derived cells (referred
to as ‘S’). The Wnt/b-catenin signaling is constitutively activated in colonosphere-derived cells, but not in parental cells as shown by the
expression of various proteins: b-catenin, phosphorylated b-catenin, axin-1, phosphorylated GSK-3-b along with important downstream targets: c-
myc and cyclin-D1. The numbers represent percent of corresponding control normalized to b-actin.
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under the influence of the microenvironment [10,44].
Currently, colon CSCs are defined by their expression of
cell surface markers, such as Musashi, LGR-5, CD44,
CD166, etc [11,13-15]. Colonospheres generated under
present conditions from the three different colon cancer
lines show increased expression of colon CSCs markers
along with pan-epithelial marker EpCAM, when com-
pared with the corresponding parental cells. Addition-
ally, the evidence for the presence of functional CSCs in
colonospheres came from the ELDA that revealed a
marked rise in frequency of sphere-forming ability of
cells in colonospheres. Since under extreme limited dilu-
tion and in serum-free conditions (stem cell media),
only stem-like cells are believed to divide to form
spheroids, our observation of formation of colono-
spheres by a very small number of cells not only sug-
gests the presence of functional CSCs in colon cancer
derived cell line but also indicate the enrichment of
CSCs in colonospheres [13,20,45].
CSCs have been shown to divide very slow and pos-
sess limited differentiation potential [10,36]. The ratio
between CSCs and differentiated cells has been sug-
gested to depend on the rate of differentiation relative
to the turnover rate of CSCs [46]. In view of this, it is
reasonable to suggest that lower the propensity to dif-
ferentiate greater the proportion of CSCs. Recent
reports have also demonstrated low functional differ-
entiation potential of colon cancer cell lines that con-
tain a high proportion of CSCs [10]. Our current data
Figure 6 Downregulation of b-catenin results in reduction of CD44 positive cells in spheroids/colonospheres and inhibits regeneration
of colonospheres. A. Flow cytometric analysis shows CD44 positive cells in HCT-116 colonospheres following 72 hrs of transfection with b-
catenin siRNA or the vector; corresponding isotypes are also shown, values represent percentage of cells that are positive for CD44-PE-Cy7. B.
Western blot showing downregulation of b-catenin and CD44 following 72 hrs of transfection of b-catenin-siRNA, compared to the vector-
control in HCT-116 colonospheres-derived cells. C. Colonosphere formation assay shows decreased regeneration of colonospheres by b-catenin-
knockdown HCT-116 colonospheres cells. The numbers represent percent of corresponding control normalized to b-actin. *p < 0.001, compared
to the corresponding vector-treated controls
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tiated as evidenced by a marked reduction in alkaline
phosphatase activity. Moreover, our observation that
colonospheres also show increased H33342 efflux cap-
abilities, accompanied by increased expression of ABC
transporter protein ABCG2 suggests that they possess
the ability to exclude drugs, a trait that has been
demonstrated for CSCs [47,48]. These observations
and the fact that over 80% of colonospheres-derived
cells are CD44 positive, a widely accepted colon CSC
marker, and that the cells of colonospheres also show
staining of EpCAM, which is believed to be a putative
CSC marker in colon cancer cell lines, strongly indi-
cate that colonospheres generated under present con-
ditions are mainly composed of CSCs.
Increasing evidence suggests that many signaling
pathways that are classically associated with cancer,
including Wnt, Hedgehog, Notch and Bmi, may also
regulate normal stem cell development. One particular
interesting pathway that has also been shown to regu-
late both self-renewal of stem cell and oncogenesis in
different organs is the Wnt signaling pathway [36]. Wnt
proteins regulate development in several organisms and
contribute to cancer when dysregulated through the
activation of b-catenin (a downstream activator of the
Wnt signaling pathway). The canonical Wnt/b-catenin
pathway has previously been reported to play a role in
hematopoietic, mammary and brain stem cell functions
[28,49,50]. The Wnt pathway is also a major regulator
of stem cells in gastrointestinal system as identification
of many different Wnt/b-catenin target genes have been
implicated in intestinal stem cell proliferation and carci-
nogenesis [37]. The best stemness-specific target of
Wnt/b-catenin signaling known today is Lgr5 [51],
while c-myc and cyclin-D1 are the other Wnt targets
associated with proliferation of progenitor cells [29,30].
Results derived from our current investigation suggest
that Wnt/b-catenin pathway plays a critical role in regu-
lating the growth and maintenance of colonospheres.
Initial support for this inference comes from the obser-
vations that there is a marked loss of membrane bound
b-catenin in colonosphere cells. Further, colonospheres
formed by colon cancer HCT-116 (wt or p53
-/-)a n d
HT-29 show a marked reducti o ni nt h ee x p r e s s i o no f
phosphorylated form of b-catenin and axin-1 and
increased levels of total b-catenin (non-phosphorylated
form) and phosphorylated form of GSK-3b, compared
to the corresponding controls. Moreover, to inactivate
Wnt/b-catenin pathway by GSK-3b, axin is required for
Figure 7 Downregulation of b-catenin inhibits transcriptional
activity of TCF/LEF in parental colon cancer cells and the
corresponding spheroids/colonospheres. TCF/LEF transcription
activity in HCT-116 wt parental and colonosphere-derived cells is
downregulated in the corresponding b-catenin transfected cells.
*p < 0.001, compared to the corresponding vector-treated controls
Figure 8 Upregulation of c-myc enhances colonospheres/spheroid formation. A. Western blot showing changes in c-myc levels in the
HCT-116 wt cells following transfections of PCMV6-vector or pCMV6-Neo vector containing human cDNA clone for c-myc gene. B.
Colonospheres formation for HCT-116 wt parental cells overexpressing c-myc. Each value represents mean ± SD of 3-4 observations. The
numbers represent percent of corresponding control normalized to b-actin. *p < 0.001, compared to the corresponding vector-treated control.
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d e c r e a s ei ne x p r e s s i o no fa x i n - 1a n db-catenin phos-
phorylation, therefore, suggests that the increased level
of total b-catenin is due to the inhibition of b-catenin
degradation. Increased levels of b-catenin, following
translocation into the nucleus, is likely to cause induc-
tion of the TCF family of transcription factors leading
to increased synthesis of several proteins that are criti-
cally involved in cellular growth [52]. Indeed, our obser-
vation that colonospheres from HCT-116 wt and HT-29
cells shows higher levels of c-myc and cyclin-D1, com-
pared to the corresponding parental cells, supports the
contention that Wnt/b-catenin signaling plays a critical
role in the formation of colonospheres. These findings
were further corroborated by the observation that
downregulation of b-catenin in the parent cell lines
decreases the number of sphere-forming cells as
demonstrated by ELDA. Furthermore, during serial pas-
saging of colonospheres, downregulation of b-catenin
causes reduction in CD44 positive cells and inhibition
in transcriptional activation of TCF/LEF resulting in
suppression of regeneration of secondary colonospheres
formation. In contrast, overexpression of c-myc is asso-
ciated with increased colonospheres formation. Taken
together, the results strongly suggest that Wnt/b-cate-
nin pathway has a pivotal role in the genesis, mainte-
nance and expansion of CSCs enriched spheroid
cultures.
In conclusion, our data demonstrate that colono-
spheres formed by colon cancer cells are predominantly
composed of cells displaying the characteristics of CSCs.
Wnt/b-catenin signaling plays a pivotal role in the
growth and maintenance of colonospheres in that down-
regulation of b-catenin that decreases TCF/LEF tran-
scriptional activity resulting in reduction of CD44
positive cells leading to a marked suppression of colono-
sphere formation and regeneration. In contrast, overex-
pression of c-myc, a downstream effector of Wnt/b-
catenin signaling, reverses the situation. We suggest that
the colonosphere formation technique is a useful in
vitro method to enrich cultures for CSCs or as a surro-
gate for tumor formation. The data presented in this
communication also provide a basis for identification of
distinctive molecular pathway(s) for self-renewal of
CSCs and for the growth and maintenance of
colonospheres.
Methods
Cell lines and culture conditions
The human colon cancer cells HCT-116 (p53 wild type;
K-ras mutant), HCT-116 (p53 null; K-ras mutant) and
H T - 2 9( p 5 3m u t a n t ;K-ras w t )w e r eo b t a i n e df r o mt h e
American Type Culture Collection (ATCC, Rockville,
MD). Cells were maintained in Dulbecco’s modified
Eagle medium (DMEM; 4.5 g/L d-glucose) supplemen-
ted with 10% FBS and 1% antibiotic/antimycotic in tis-
sue culture flasks in a humidified incubator at 37°C in
an atmosphere of 95% air and 5% carbon dioxide. The
medium was changed twice a week, and the cells were
passaged using 0.05% trypsin/EDTA.
Antibodies
Antibodies used for immunofluorescence, or Western
blotting were as follows: rabbit anti-LGR5/GPR49
(Abgent, San Diego, CA), mouse anti-b-actin (Chemicon
International, Billerica, MA), mouse anti-CD44 (Abcam
I n c . ,C a m b r i d g e ,M A ) ,r a b b i ta n t i - M u s a s h i - 1( I m g e n e x ,
San Diego, CA), mouse anti-cyclin-D1, rabbit anti-
ABCG2, mouse anti-b-catenin (Santa Cruz Biotechnol-
ogy Inc., Santa Cruz, CA); rabbit anti-c-myc, mouse
anti-EpCAM, mouse anti-CD44, rabbit anti-axin1, rabbit
anti-phospho-b- c a t e n i n ,C e l lS i g n a l i n g ,D a n v e r s ,M A )
and FITC-conjugated mouse-IgG2b (Sigma-Aldrich Inc,
St Louis, MO). Mouse anti-human PerCP-Cy5 IgG2b
(isotype) or CD44 conjugated antibodies (Santa Cruz
Biotechnology Inc., Santa Cruz, CA) and mouse anti-
human PE-Cy7 IgG2b (isotype) or CD44 conjugated
antibodies (BD Pharmingen) were used for flow
cytometry.
Western blotting
For all Western blot analyses, protein was harvested from
adherent cells and colonospheres. Cell lysates were pre-
pared by homogenizing the cells in lysis buffer as pre-
viously described [22]. Quantification of the proteins was
carried out using a modified Bradford assay (Bio-Rad
Laboratories). Protein samples for Western blotting were
prepared by boiling after the addition of denaturing sam-
ple buffer. Proteins were separated using SDS-PAGE on
an 8% or 15% gel and transferred to a polyvinylidene
difluoride membrane (Millipore) by electroblotting. Anti-
bodies were diluted in TBS and 0.1% (v/v) Tween with
5% nonfat dry milk after 1 h of protein blocking in the
absence of antibodies. Membranes were incubated at 4°C
overnight with the primary antibody, subsequently
washed and incubated with the appropriate horseradish
peroxidase-conjugated secondary antibody (Amersham
Biosciences) for 1 h at room temperature. Membranes
were again washed, and protein bands were visualized
using a commercially available enhanced chemilumines-
cence kit (Amersham Biosciences). When appropriate,
membranes were incubated in stripping solution for
30 min at 65°C, washed, and re-probed with a second pri-
mary antibody for verification of loading control.
Formation of colonospheres
The ability of cell lines to form spheres in suspension
was evaluated as described by Liu et al. [25], with
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were generated by incubating the limited number of
parental HCT-116 (p53 wild-type; K-ras mutant),
HCT-116 (p53 null; K-ras mutant) and HT-29 (p53
mutant; K-ras wild-type) cells at a concentration of
100 cells per 200 μL in serum-free stem cell medium
(SCM) containing DMEM/F12 (1:1) supplemented with
B27 (Life Technologies, Gaithersburg, MD), 20 ng/ml
EGF (Sigma, St Louis, MO), 10 ng/ml fibroblast
growth factor (Sigma), and antibiotic-anti-mycotic in
24-well ultra low-attachment plates (Corning Inc, Low-
ell, MA) for 10 days. The colonospheres formed at the
end of the incubation period were centrifuged (1000
rpm), dissociated with 0.05% trypsin/EDTA using a 22
gauge needle and then passed through a 40 μMs i e v e
to obtain single cell suspension, as described by Kakar-
ala et al. [19]. The single-cell suspension derived from
colonospheres that have undergone 15 or more serial
passages were used for all experiments. For spheroids
formation, an equal number of cells from adherent cell
lines and colonospheres cells were plated at 200 cells/
100 μL SCM in each 96 ultra low-attachment well
(Corning Inc, Lowell, MA). The colonospheres formed
after 5 days were evaluated for their number and size
by light microscopy.
Extreme limiting dilution analysis
Extreme limiting dilution analysis (ELDA) was per-
formed as described by Hu and Smyth [45]. Briefly, sin-
gle cell suspension obtained from adherent or
colonospheres-derived cells were plated at concentration
of 1000, 100, 10 cells and 1 cell per 100 μlS C M( 2 4
well for each dilution) in 96-well ultra-low attachment
and incubated for 5 days. At the end of 5 days, the
number of wells showing formation of colonospheres
was counted. The frequency of sphere forming cells in a
particular cell type was determined using ELDA webtool
at http://bioinf.wehi.edu.au/software/elda.
Flow Cytometry Analysis
Single cell suspension from parental monolayer cell
cultures and colonospheres were subjected to direct
immunofluorescence staining followed by flow cytome-
try analysis according to our standard protocol [22].
Briefly, the cells were harvested and washed with PBS.
Half a million cells were suspended in 90 μlo fP B S
containing 0.5% BSA. After 10 min at room tempera-
ture, 10 μl of fluorophore conjugated anti-human
CD44 antibody was added and incubated for 30 min in
dark at room temperature. The samples were then
washed and analyzed using a FACS DiVa (BD, San
Jose, CA). The cells stained with mouse IgG2b (iso-
type-negative control) served as gating control. The
proportion of CD44 positive cells was determined on
the basis of fluorescence intensity-spectra of CD44-
conjugated PE-Cy7 or PerCP-Cy5.
Immunofluorescence cytochemistry
Single cell suspension, obtained from parental and colo-
nosphere, was washed in PBS and fixed in 2-4% formal-
dehyde for 10 min at 37 °C. They were washed and re-
suspended in 0.5% BSA-PBS (blocking buffer) for 10 min,
subsequently incubated in primary antibodies at appro-
priate dilution for 1 h at room temperature. After rinsing
with incubation buffer, the cells were resuspended in
fluorophore-conjugated secondary antibodies diluted in
incubation buffer according to the manufacturer’s recom-
mendations and incubated for 30 minutes at room tem-
perature. The cells were then resuspended in PBS after
washing with the incubation buffer. Appropriate aliquot
of cells were mounted on glass slides immediately before
examining under fluorescence microscope.
Hoechst 33342 dye exclusion assay
Single cell suspension obtained from parental cell lines
and colonospheres were washed with PBS (3 times) and
stained with Hoechst 33342 or H342 (5 μg/ml, Sigma-
Aldrich Inc, St Louis, MO) for 45 minutes at 37°C in
HBSS buffer, vortexing gently every 15 min. As a con-
trol, a sample was treated with verapamil (Sigma,
50 μM) for ten minutes at room temperature prior to
the addition of H342. The stained cells were collected,
washed with PBS and resuspended in 3 ml of PBS con-
taining 2 μg/ml of propidium iodide, and subsequently
analyzed by flow cytometer-FACS Vantage SE/DiVa
SORP (BD Biosciences, San Jose, CA) with all-digital
electronics and octagon- and trigon-shaped detector
arrays. Excitation of 100 mW at 488 nm was provided
by a 177-G argon ion laser (Spectra-Physics, Mountain
View, CA) and 200 mW of all-lines UV (351-365 nm)
was provided by an Innova 90-5 argon ion laser (Coher-
ent, Palo Alto, CA). Forward and side laser scatter was
detected from 488 nm excitation. H342 and propidium
iodide fluorescence from UV excitation was split into
“blue” and “red” wavelengths by a 505 nm long pass
dichroic with a 450/50 bandpass (425-475 nm) filter in
front of the “blue” detector and a 630 nm long pass fil-
ter in front of the “red” detector. Cell population show-
ing H342 Bright (H342
Br) and H342 Low (H342
Lo)w a s
determined and the ratio of H342
Lo/H3342
Br was calcu-
lated to evaluate the dye-efflux capacities of the cells.
The gating of H342
Lo and H342
Br cells was based on a
verapamil control. Dead cells were gated out based on
positive staining with propidium iodide.
Determination of cellular growth
Changes in cellular growth, an assessment of prolifera-
tion, of parental and colonosphere-derived cells were
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trazolium bromide (MTT) assay as described previously
[22]. Briefly, 4000 cells were plated per well in 96-well
plates in 200 μl medium. At each time point (0, 24, 48,
72, 96, 120 h), 20 μl MTT solution was added to each
well and the plate was incubated for 1 h at 37°C. Med-
ium was then aspirated from each well, and 100 μl
DMSO was added. The intensity of the color developed,
which is the reflection of number of live cells, was mea-
sured at a wavelength of 570 nm. All values were com-
pared to the corresponding controls. All assays were
performed with 6 replicates.
Measurement of Alkaline phosphatase activity
Status of differentiation was determined by measuring
the alkaline phosphatase activity using SensoLyte, pNPP
alkaline phosphatase assay kit (Anaspec, San Jose, CA)
according to the manufacturer’s instructions and mea-
suring the absorbance at 405 nm.
b-catenin siRNA transfection
For the transfection of siRNA into the parental and
colonosphere derived cells, Oligofectamine reagent
(Invitrogen Corp., Carlsbad, CA) and serum-free Opti-
MEM (Invitrogen Corp., Carlsbad, CA) medium was
used to prepare transfection complexes according to the
manufacturer’s instructions. Briefly, single cell suspen-
sion of colonospheres was plated in 10 cm tissue culture
plates with normal growth medium overnight to achieve
25-30% confluence. Next day the medium was removed,
washed twice with serum-free Opti-MEM (Invitrogen
Corp., Carlsbad, CA) medium prior to adding the com-
plexes containing non-targeted or b-catenin siRNA
(Integrated DNA Technologies Inc., Coralville, IA).
After 3 days of transfection, the cells were collected and
analyzed for protein expression of b-catenin using Wes-
tern blot and for colonosphere formation assay using
SCM.
Activation of relative TCF/LEF-Dual Luciferase assay
The activation of transcription factor TCF/LEF was eval-
uated by using Cignal TCF/LEF reporter assay kit (SA
Biosciences, Frederick, MD). The cells were grown to
25-30% confluence as described above and co-trans-
fected with TCF/LEF reporter constructs and either
non-targeted or b-catenin siRNAs (Integrated DNA
Technologies Inc., Coralville, IA) using SureFECT trans-
fection reagent (SA Biosciences, Frederick, MD) accord-
ing to manufacturer’s instructions. The TCF/LEF
reporter used a mixture of an inducible b-catenin-
responsive luciferase construct and a constitutively
expressing Renilla element (40:1). At the end of 16-24 h
incubation period Opti-MEM medium was changed to
DMEM 10% FBS for parental cell lines or SCM for
colonosphere derived cells. The cells were allowed to
grow for another 3 days, collected and analyzed for
TCF/LEF activity using a dual-luciferase assay kit (Pro-
mega-Biosciences, San Luis Obispo, CA) following the
instructions outlined by the manufacturer.
Overexpression of c-myc gene
Single cell suspension of HCT-116 parental cells was
plated in the tissue culture plates to achieve a 90% con-
fluence. Once the 90% confluence is achieved, the
adherent cells were transfected using Lipofectamine
2000 and PLUS reagent (Invitrogen Corp., Carlsbad,
CA) with plasmid vector-pCMV6-Neo (Origene, Rock-
ville, MD) containing human cDNA clone for c-myc
gene or empty plasmid PCMV6-vector in OPTI-MEM
medium according to the manufacturer’si n s t r u c t i o n .
After 3 days of transfection, the cells were analyzed for
c-myc protein expression by Western blot and re-plated
for colonosphere formation assay.
Statistical analysis
Unless otherwise stated, data are expressed as mean ±
SD of six observations. Where applicable, the results
were analyzed using analysis of variance followed by
Fisher protected least significant differences or Scheffé
test. p < 0.01 was designated as the level of significance.
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